Sustainable development
2024 Scope 3 Greenhouse Gas Inventory Data
Release time:
2025-09-26
2024 Scope 3 Greenhouse Gas Inventory Data
In 2024, the company conducted its inaugural Scope 3 greenhouse gas inventory, undertaking an in-depth assessment of carbon emissions across its upstream and downstream value chain to actively implement the concept of low-carbon operations. For the reporting year, Livzon Pharmaceutical Group Inc.’s Scope 3 greenhouse gas emissions amounted to 1,709,496.18 metric tons.
For further details regarding the climate strategy and climate risk management measures, please refer to the Livzon Pharmaceutical Group Inc. 2024 Environmental, Social, and Governance Report.
Indirect Greenhouse Gas Emissions Scope 3 (location-based) | ||||||||||||||||
Scope 3 Category | 1：Purchased goods and services | 2：Capital goods | 3：Fuel-and-energy-related-activities (not included in Scope 1 or 2) | 4：Upstream transportation and distribution | 5：Waste generated in operations | 6：Business travel | 7：Employee commuting | 8：Upstream leased assets | 9：Downstream transportation and distribution | 10：Processing of sold products | 11：Use of sold products | 12：End-of-life treatment of sold products | 13：Downstream leased assets | 14：Franchises | 15：Investments | Total |
Emissions in the reporting year (metric tonnes CO2e) | 1304339.26 | 3950.05 | 121316.88 | 85395.73 | 32556 | 6143.9 | 51662.2 | 498.32 | 600.89 | 58532.53 | 3335.82 | 31.45 | 1202.12 | 0 | 39931.03 | 1709496.18 |
Previous Page